It is a well known fact that breastfeeding is best source of nutrition for infants. Breast milk provides minerals, vitamins and antibodies in most acceptable format when they need it. Nutrition taken by mother passes to breast-milk and same thing applies to medicines taken by mothers. Not all drugs cause problem for baby but some do. Lets analyze if Azithromycin | Northwind Pharmaceuticals is safe for baby while breastfed.
What is Azithromycin | Northwind Pharmaceuticals used for?
To reduce the development of drug-resistant bacteria and maintain the effectiveness of azithromycin tablets and other antibacterial drugs, azithromycin tablets should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. Azithromycin tablets are a macrolide antibacterial drug indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the specific conditions listed below. Recommended dosages and durations of therapy in adult and pediatric patient populations vary in these indications [see Dosage and Administration ( 2)]. Azithromycin tablets are a macrolide antibacterial drug indicated for mild to moderate infections caused by designated, susceptible bacteria: Acute bacterial exacerbations of chronic bronchitis in adults ( 1.1) Acute bacterial sinusitis in adults ( 1.1) Uncomplicated skin and skin structure infections in adults ( 1.1) Urethritis and cervicitis in adults ( 1.1) Genital ulcer disease in men ( 1.1) Acute otitis media in pediatric patients ( 1.2) Community-acquired pneumonia in adults and pediatric patients ( 1.1, 1.2) Pharyngitis/tonsillitis in adults and pediatric patients ( 1.1, 1.2) Limitation of Use: Azithromycin should not be used in patients with pneumonia who are judged to be inappropriate for oral therapy because of moderate to severe illness or risk factors. ( 1.3) To reduce the development of drug-resistant bacteria and maintain the effectiveness of azithromycin tablets and other antibacterial drugs, azithromycin tablets should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria. 1.1 Adult Patients Acute bacterial exacerbations of chronic bronchitis due to Haemophilus influenzae, Moraxella catarrhalis, or Streptococcus pneumoniae. Acute bacterial sinusitis due to Haemophilus influenzae, Moraxella catarrhalis. or Streptococcus pneumoniae. Community-acquired pneumonia due to Chlamydophila pneumoniae, Haemophilus influenzae, Mycoplasma pneumoniae, or Streptococcus pneumoniae in patients appropriate for oral therapy. Pharyngitis/tonsillitis caused by Streptococcus pyogenes as an alternative to first-line therapy in individuals who cannot use first-line therapy. Uncomplicated skin and skin structure infections due to Staphylococcus aureus, Streptococcus pyogenes, or Streptococcus agalactiae. Urethritis and cervicitis due to Chlamydia trachomatis or Neisseria gonorrhoeae. Genital ulcer disease in men due to Haemophilus ducreyi (chancroid). Due to the small number of women included in clinical trials, the efficacy of azithromycin in the treatment of chancroid in women has not been established. 1.2 Pediatric Patients [see Use in Specific Populations ( 8.4) and Clinical Studies ( 14.2)] Acute otitis media (> 6 months of age) caused by Haemophilus influenzae, Moraxella catarrhalis, or Streptococcus pneumoniae Community-acquired pneumonia (> 6 months of age) due to Chlamydophila pneumoniae, Haemophilus influenzae, Mycoplasma pneumonia, or Streptococcus pneumoniae in patients appropriate for oral therapy. Pharyngitis/tonsillitis (> 2 years of age) caused by Streptococcus pyogenes as an alternative to first-line therapy in individuals who cannot use first-line therapy. 1.3 Limitations of Use Azithromycin should not be used in patients with pneumonia who are judged to be inappropriate for oral therapy because of moderate to severe illness or risk factors such as any of the following: patients with cystic fibrosis, patients with nosocomial infections, patients with known or suspected bacteremia, patients requiring hospitalization, elderly or debilitated patients, or patients with significant underlying health problems that may compromise their ability to respond to their illness (including immunodeficiency or functional asplenia).
What are the risk associated with Azithromycin | Northwind Pharmaceuticals usage while breastfeeding? What precautions shall I take while using it in breastfeeding?
Azithromycin anhydrous is the only one ingredient used in manufacturing of Azithromycin | Northwind Pharmaceuticals, Which makes it easier to analyze its effect in breastfeeding. As per our analysis of Azithromycin anhydrous it is safe to use Azithromycin | Northwind Pharmaceuticals while lactating. We suggest you to check further details below about Azithromycin anhydrous usage in breastfeeding.
Statement of Manufacturer/Labeler about breastfeeding usage
8.3 Nursing Mothers Azithromycin has been reported to be excreted in human breast milk in small amounts. Caution should be exercised when azithromycin is administered to a nursing woman.
Azithromycin | Northwind Pharmaceuticals Breastfeeding Analsys
Azithromycin anhydrous while Breastfeeding Safe
CAS Number: 83905-01-5
Excreted in very low levels into breast milk and commonly used for pediatric treatment. Early exposition to Macrolides (mostly Erythromycin) have been related to hypertrophic pyloric stenosis. Avoiding use in the first post-partum month would be advisable yet it may occurred while breastfeeding. Be aware of false negative bacterial cultures in the infant when the mother is on antibiotics. Also, diarrheal disease due to imbalance of intestinal flora is possible.
Azithromycin | Northwind Pharmaceuticals Breastfeeding Analsys - 2
Azithromycin anhydrous while Breastfeeding
CAS Number: 83905-01-5
Because of the low levels of azithromycin in breastmilk and use in infants in higher doses, it would not be expected to cause adverse effects in breastfed infants. Monitor the infant for possible effects on the gastrointestinal flora, such as diarrhea, candidiasis (thrush, diaper rash). Unconfirmed epidemiologic evidence indicates that the risk of hypertrophic pyloric stenosis in infants might be increased by maternal use of macrolide antibiotics during breastfeeding. A single dose of azithromycin given during labor to women who were nasal carriers of pathogenic and reduced the counts of these bacteria in breastmilk in one study.
What should I do if already breastfed my kid after using Azithromycin | Northwind Pharmaceuticals?
It is always a good idea to keep your healthcare provider or doctor informed about your drug usage during pregnancy and breastfeeding but if you have not informed your doctor about Azithromycin | Northwind Pharmaceuticals and have used it then do not panic as Azithromycin | Northwind Pharmaceuticals is mostly safe in breastfeeding and should not cause any harm to your baby.
I am nursing mother and my doctor has suggested me to use Azithromycin | Northwind Pharmaceuticals, is it safe?
Definitely, Azithromycin | Northwind Pharmaceuticals is safe in lactation for baby. No wonder your doctor has recommended it.
If I am using Azithromycin | Northwind Pharmaceuticals, will my baby need extra monitoring?
No extra baby monitoring required while mother is using Azithromycin | Northwind Pharmaceuticals
Who can I talk to if I have questions about usage of Azithromycin | Northwind Pharmaceuticals in breastfeeding?
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week